EUVIMEDEUVIMED entdecken
Crossref

Serum FcεRI as a Putative Biomarker of Disease Severity and Immune Perturbation in Paediatric and Adult Atopic Dermatitis

Bandar Ibrahim AAYF AL-SHAMMARI, Rojan Ghanim MOHAMMED AL-ALLAFF

Asthma Allergy Immunology · 23.12.2025 · 23 (3) · 251-262

DOI: 10.21911/aai.2025.863 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Asthma Allergy Immunology, online erschienen am 23.12.2025. Verfasst von Bandar Ibrahim AAYF AL-SHAMMARI und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

AL-SHAMMARI, B. I. A., & AL-ALLAFF, R. G. M. (2025). Serum FcεRI as a Putative Biomarker of Disease Severity and Immune Perturbation in Paediatric and Adult Atopic Dermatitis. Asthma Allergy Immunology, 23(3), 251-262. https://doi.org/10.21911/aai.2025.863

Vancouver

AL-SHAMMARI BIA, AL-ALLAFF RGM. Serum FcεRI as a Putative Biomarker of Disease Severity and Immune Perturbation in Paediatric and Adult Atopic Dermatitis. Asthma Allergy Immunology. 2025;23(3):251-262. doi:10.21911/aai.2025.863

BibTeX
@article{ALSHAMMARI2025,
  author = {AL-SHAMMARI, Bandar Ibrahim AAYF and AL-ALLAFF, Rojan Ghanim MOHAMMED},
  title = {Serum FcεRI as a Putative Biomarker of Disease Severity and Immune Perturbation in Paediatric and Adult Atopic Dermatitis},
  journal = {Asthma Allergy Immunology},
  year = {2025},
  volume = {23},
  number = {3},
  pages = {251--262},
  doi = {10.21911/aai.2025.863}
}
Kostenlos starten →